pathological complete response
Showing 1 - 25 of >10,000
Axillary Lymph Node Dissection, Pathological Complete Response, Neoadjuvant Systemic Therapy Trial in Nanjing (Stained region
Recruiting
- Axillary Lymph Node Dissection
- +4 more
- Stained region Lymph Node Biopsy (SrLNB)
- Regional lymph node radiotherapy (RNI) including the axilla
-
Nanjing, ChinaThe First Affiliated Hospital of Nanjing Medical University
Jul 10, 2023
Early Predict Pathological Complete Response to Neoadjuvant
Recruiting
- Breast Cancer
-
Guangzhou, Guangdong, ChinaGuangdong Provincial People's Hospital
Aug 8, 2022
Refusal of Breast Surgery in Patients With Breast Cancer With a cCR After NST and a Confirmed Pathological Complete Response
Recruiting
- Refusal of Breast Surgery in Patients With Breast Cancer With a cCR After NST and a Confirmed Pathological Complete Response (pCR) Using VAB and SLNB
- Vacuum-assisted biopsy
-
Saint-Petersburg, Russian FederationPetr Krivorotko
Jun 14, 2022
Head and Neck Squamous Cell Carcinoma Trial in Zhuhai (dose-reduced radiotherapy)
Recruiting
- Head and Neck Squamous Cell Carcinoma
- dose-reduced radiotherapy
-
Zhuhai, Guangdong, ChinaFifth Affiliated Hospital of Sun Yat-sen University
May 3, 2023
Triple Negative Breast Tumors Trial (Xiaopi granules, Xiaopi decoction, Placebo)
Not yet recruiting
- Triple Negative Breast Neoplasms
- Xiaopi granules
- +2 more
- (no location specified)
Nov 22, 2023
HER2-positive Breast Cancer Trial in Rome (PIK3CA analysis)
Active, not recruiting
- HER2-positive Breast Cancer
- PIK3CA analysis
-
Rome, RM, ItalyFondazione Policlinico Universitario Agostino Gemelli IRCCS
Feb 20, 2023
Anatomic Stage IIIB Breast Cancer AJCC v8, Anatomic Stage IIIC Breast Cancer AJCC v8, Breast Inflammatory Carcinoma Trial in
Active, not recruiting
- Anatomic Stage IIIB Breast Cancer AJCC v8
- +4 more
- Pembrolizumab
-
Houston, TexasM D Anderson Cancer Center
Sep 30, 2022
Breast Cancer Trial in Ottawa (Trastuzumab)
Recruiting
- Breast Cancer
-
Ottawa, Ontario, CanadaThe Ottawa Hospital Cancer Centre
Apr 26, 2022
Neoadjuvant Chemoimmunotherapy in Non-small Cell Lung Cancer
Recruiting
- Non-small Cell Lung Cancer
- +2 more
- CT/PET/WSI-based Deep Learning Signature
-
Zunyi, Guizhou, China
- +2 more
Jun 27, 2023
HER2-negative Breast Cancer, Neoadjuvant Therapy, Pathological Complete Response Trial in Beijing (Camrelizumab with vinorelbine
Recruiting
- HER2-negative Breast Cancer
- +5 more
- Camrelizumab with vinorelbine and cisplatin
-
Beijing, Beijing, ChinaPeking University First Hospital
Oct 15, 2022
Breast Cancer Trial (Physical training)
Not yet recruiting
- Breast Cancer
- Physical training
- (no location specified)
Jan 7, 2022
Assessment Model of PCR After NAT on Breast Cancer AI Technology
Recruiting
- Breast Cancer
- Neoadjuvant therapy
-
Beijing, Beijing, ChinaNational Cancer Center/National Clinical Research Center for Can
Jun 30, 2022
Prostate Cancer Trial in Canada (Abiraterone acetate with prednisone, Leuprolide, Cabazitaxel with peg-filgrastim)
Completed
- Prostate Cancer
- Abiraterone acetate with prednisone
- +2 more
-
Vancouver, British Columbia, Canada
- +4 more
Apr 13, 2022
Fasting Mimicking Diet, HER2-negative Breast Cancer, Hormone Receptor-positive Breast Cancer Trial in Netherlands (Fasting
Not yet recruiting
- Fasting Mimicking Diet
- +5 more
- Fasting Mimicking diet program
-
Alkmaar, Netherlands
- +14 more
Aug 15, 2022
Breast Tumor, Neoadjuvant Therapy, Axillary Lymph Nodes Trial in Netherlands (RISAS)
Completed
- Breast Neoplasm
- +3 more
- RISAS
-
Assen, Netherlands
- +13 more
Feb 9, 2022
Rectal Cancer Trial in Guangzhou (watch and wait)
Recruiting
- Rectal Cancer
- watch and wait
-
Guangzhou, Guangdong, ChinaSun Yatsen University
May 10, 2021
Breast Cancer Trial in United States (Positron emission tomography (PET), Trastuzumab, Pertuzumab)
Active, not recruiting
- Breast Cancer
- Positron emission tomography (PET)
- +2 more
-
Birmingham, Alabama
- +9 more
Jan 20, 2023
Neoadjuvant Chemoradiotherapy, Locally Advanced Rectal Cancer, Pathological Complete Response Trial in Roma (RT Dose escalation
Recruiting
- Neoadjuvant Chemoradiotherapy
- +2 more
- RT Dose escalation in LARC patients with an Early Regression Index > 13.1 at second week on nCRT
-
Roma, ItalyFondazione Policlinico Universitario A.Gemelli IRCCS
Mar 22, 2021
Breast Cancer Female, Chemo Effect Trial in Milano (MAMMOT2)
Recruiting
- Breast Cancer Female
- Chemotherapy Effect
- MAMMOT2
-
Milano, ItalyOspedale San Raffaele
Feb 22, 2021
Histology VABB-Histology Post Surgery Pilot Project
Active, not recruiting
- Breast Cancer
- vacuum-assisted breast biopsy
-
Milan, ItalyEuropean Instituto of Oncology
Oct 25, 2021
Breast Cancer Patients
Completed
- Neoadjuvant Chemotherapy
- Neoadjuvant therapy
-
Istanbul, TurkeyAcıbademAH
Nov 21, 2023
t Pathologic Complete Response Observed in HER2 Positive Breast
Completed
- HER2+ Breast Cancer
-
Rawalpindi, Punjab, PakistanRawalpindi Medical University
Jun 26, 2023
Breast Tumors Trial in Heidelberg (Vacuum-Assisted Biopsy)
Completed
- Breast Neoplasms
- Vacuum-Assisted Biopsy
-
Heidelberg, Baden-Württemberg, GermanyUniversity Breast Unit, Department of Gynecology, University of
Mar 23, 2020
MRI Criterion After Neoadjuvant Therapy in Locally Advanced
Completed
- Rectal Neoplasms
-
Nîmes, Gard, FranceChu de Nîmes
Sep 8, 2022
Breast Cancer Trial in Angers, Saint-Herblain (Biopsy, Blood samples, Questionnaires)
Not yet recruiting
- Breast Cancer
- Biopsy
- +2 more
-
Angers, France
- +1 more
Jul 31, 2023